146 related articles for article (PubMed ID: 30569573)
21. P38 MAPK Promotes Migration and Metastatic Activity of BRAF Mutant Melanoma Cells by Inducing Degradation of PMCA4b.
Naffa R; Vogel L; Hegedűs L; Pászty K; Tóth S; Kelemen K; Singh N; Reményi A; Kállay E; Cserepes M; Tóvári J; Grusch M; Enyedi Á
Cells; 2020 May; 9(5):. PubMed ID: 32414111
[TBL] [Abstract][Full Text] [Related]
22. Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation.
Coulombe P; Rodier G; Pelletier S; Pellerin J; Meloche S
Mol Cell Biol; 2003 Jul; 23(13):4542-58. PubMed ID: 12808096
[TBL] [Abstract][Full Text] [Related]
23. Contextual role of E2F1 in suppression of melanoma cell motility and invasiveness.
Meng P; Bedolla RG; Yun H; Fitzpatrick JE; Kumar AP; Ghosh R
Mol Carcinog; 2019 Sep; 58(9):1701-1710. PubMed ID: 31124185
[TBL] [Abstract][Full Text] [Related]
24. Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.
Mathien S; Déléris P; Soulez M; Voisin L; Meloche S
Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28167606
[TBL] [Abstract][Full Text] [Related]
25. C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis.
Tanguay PL; Rodier G; Meloche S
Biochem J; 2010 Apr; 428(1):103-11. PubMed ID: 20236090
[TBL] [Abstract][Full Text] [Related]
26. Conditional ERK3 overexpression cooperates with PTEN deletion to promote lung adenocarcinoma formation in mice.
Vallabhaneni S; Liu J; Morel M; Wang J; DeMayo FJ; Long W
Mol Oncol; 2022 Mar; 16(5):1184-1199. PubMed ID: 34719109
[TBL] [Abstract][Full Text] [Related]
27. The extracellular signal-regulated kinase 3 (mitogen-activated protein kinase 6 [MAPK6])-MAPK-activated protein kinase 5 signaling complex regulates septin function and dendrite morphology.
Brand F; Schumacher S; Kant S; Menon MB; Simon R; Turgeon B; Britsch S; Meloche S; Gaestel M; Kotlyarov A
Mol Cell Biol; 2012 Jul; 32(13):2467-78. PubMed ID: 22508986
[TBL] [Abstract][Full Text] [Related]
28. Scaffolding by ERK3 regulates MK5 in development.
Schumacher S; Laass K; Kant S; Shi Y; Visel A; Gruber AD; Kotlyarov A; Gaestel M
EMBO J; 2004 Dec; 23(24):4770-9. PubMed ID: 15538386
[TBL] [Abstract][Full Text] [Related]
29. MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression.
Yang W; Khoury E; Guo Q; Prabhu SA; Emond A; Huang F; Gonçalves C; Zhan Y; Plourde D; Nichol JN; Dahabieh MS; Miller WH; Del Rincón SV
Oncogene; 2020 Apr; 39(18):3650-3665. PubMed ID: 32132651
[TBL] [Abstract][Full Text] [Related]
30. ERK3 promotes endothelial cell functions by upregulating SRC-3/SP1-mediated VEGFR2 expression.
Wang W; Bian K; Vallabhaneni S; Zhang B; Wu RC; O'Malley BW; Long W
J Cell Physiol; 2014 Oct; 229(10):1529-37. PubMed ID: 24585635
[TBL] [Abstract][Full Text] [Related]
31. Targeting ERK3/MK5 complex for treatment of obesity and diabetes.
Loza-Valdes A; El-Merahbi R; Kassouf T; Demczuk A; Reuter S; Viera JT; Karwen T; Noh M; Löffler MC; Romero-Becerra R; Torres JL; Marcos M; Sabio G; Wojda U; Sumara G
Biochem Biophys Res Commun; 2022 Jul; 612():119-125. PubMed ID: 35523049
[TBL] [Abstract][Full Text] [Related]
32. Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity.
De la Mota-Peynado A; Chernoff J; Beeser A
J Biol Chem; 2011 Apr; 286(15):13603-11. PubMed ID: 21317288
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth.
Jin Y; Pan Y; Zheng S; Liu Y; Xu J; Peng Y; Zhang Z; Wang Y; Xiong Y; Xu L; Mu K; Chen S; Zheng F; Yuan Y; Fu J
Oncogene; 2022 Mar; 41(12):1752-1766. PubMed ID: 35124697
[TBL] [Abstract][Full Text] [Related]
34. ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization.
Bogucka-Janczi K; Harms G; Coissieux MM; Bentires-Alj M; Thiede B; Rajalingam K
Elife; 2023 Apr; 12():. PubMed ID: 37057894
[TBL] [Abstract][Full Text] [Related]
35. Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality.
Klinger S; Turgeon B; Lévesque K; Wood GA; Aagaard-Tillery KM; Meloche S
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16710-5. PubMed ID: 19805361
[TBL] [Abstract][Full Text] [Related]
36. ERK3-MK5 signaling regulates myogenic differentiation and muscle regeneration by promoting FoxO3 degradation.
Soulez M; Tanguay PL; Dô F; Dort J; Crist C; Kotlyarov A; Gaestel M; Ferron M; Dumont NA; Meloche S
J Cell Physiol; 2022 Apr; 237(4):2271-2287. PubMed ID: 35141958
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.
Huntington JT; Shields JM; Der CJ; Wyatt CA; Benbow U; Slingluff CL; Brinckerhoff CE
J Biol Chem; 2004 Aug; 279(32):33168-76. PubMed ID: 15184373
[TBL] [Abstract][Full Text] [Related]
38. The non-classical MAP kinase ERK3 controls T cell activation.
Marquis M; Boulet S; Mathien S; Rousseau J; Thébault P; Daudelin JF; Rooney J; Turgeon B; Beauchamp C; Meloche S; Labrecque N
PLoS One; 2014; 9(1):e86681. PubMed ID: 24475167
[TBL] [Abstract][Full Text] [Related]
39. The protein kinase ERK3 is encoded by a single functional gene: genomic analysis of the ERK3 gene family.
Turgeon B; Lang BF; Meloche S
Genomics; 2002 Dec; 80(6):673-80. PubMed ID: 12504858
[TBL] [Abstract][Full Text] [Related]
40. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
Li L; Zhang S; Li H; Chou H
BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
